Keefe, Bruyette & Woods Boosts Hamilton Lane (NASDAQ:HLNE) Price Target to $215.00

Hamilton Lane (NASDAQ:HLNE) had its price target lifted by research analysts at Keefe, Bruyette & Woods from $181.00 to $215.00 in a report issued on Thursday, Benzinga reports. The firm presently has a “market perform” rating on the stock. Keefe, Bruyette & Woods’ target price would indicate a potential upside of 12.34% from the company’s previous close.

Several other analysts have also recently commented on the stock. Morgan Stanley raised their price target on shares of Hamilton Lane from $140.00 to $182.00 and gave the stock an “equal weight” rating in a report on Thursday, October 10th. JPMorgan Chase & Co. upped their price target on shares of Hamilton Lane from $120.00 to $134.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 7th. UBS Group boosted their target price on Hamilton Lane from $150.00 to $185.00 and gave the company a “neutral” rating in a research note on Tuesday, October 22nd. The Goldman Sachs Group raised their price target on Hamilton Lane from $139.00 to $147.00 and gave the stock a “neutral” rating in a research note on Thursday, October 3rd. Finally, Wells Fargo & Company boosted their price target on Hamilton Lane from $156.00 to $170.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 9th. Seven analysts have rated the stock with a hold rating, Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $172.17.

Hamilton Lane Price Performance

HLNE stock traded down $1.25 during trading on Thursday, hitting $191.38. The company had a trading volume of 24,420 shares, compared to its average volume of 314,979. Hamilton Lane has a fifty-two week low of $86.20 and a fifty-two week high of $196.60. The company has a current ratio of 2.72, a quick ratio of 2.72 and a debt-to-equity ratio of 0.27. The firm has a market capitalization of $10.37 billion, a price-to-earnings ratio of 44.00 and a beta of 1.18. The business has a 50 day moving average of $167.61 and a 200 day moving average of $141.67.

Hamilton Lane (NASDAQ:HLNE) last released its quarterly earnings data on Wednesday, November 6th. The company reported $1.07 earnings per share for the quarter, topping the consensus estimate of $1.06 by $0.01. Hamilton Lane had a return on equity of 34.36% and a net margin of 26.99%. The business had revenue of $150.00 million during the quarter, compared to analyst estimates of $151.55 million. During the same period last year, the company posted $0.89 EPS. The company’s revenue was up 18.2% compared to the same quarter last year. As a group, research analysts predict that Hamilton Lane will post 4.9 earnings per share for the current year.

Hedge Funds Weigh In On Hamilton Lane

Large investors have recently added to or reduced their stakes in the company. BNP Paribas Financial Markets raised its stake in Hamilton Lane by 25.6% during the first quarter. BNP Paribas Financial Markets now owns 27,218 shares of the company’s stock worth $3,069,000 after acquiring an additional 5,549 shares in the last quarter. Janney Montgomery Scott LLC increased its holdings in shares of Hamilton Lane by 14.5% in the first quarter. Janney Montgomery Scott LLC now owns 4,522 shares of the company’s stock valued at $510,000 after purchasing an additional 571 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S bought a new position in Hamilton Lane in the 1st quarter worth approximately $134,000. Quantbot Technologies LP acquired a new stake in shares of Hamilton Lane in the 1st quarter valued at $1,201,000. Finally, SG Americas Securities LLC bought a new stake in shares of Hamilton Lane during the first quarter worth $538,000. Institutional investors and hedge funds own 97.40% of the company’s stock.

Hamilton Lane Company Profile

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.